Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05287854
Other study ID # ICO-2021-14
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 16, 2022
Est. completion date January 2024

Study information

Verified date February 2023
Source Institut Cancerologie de l'Ouest
Contact Audrey BECMEUR, Nurse
Phone +(00)33240679900
Email audrey.becmeur@ico.unicancer.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Virtual Reality (VR) is an interactive and immersive technology that allows you to evolve in a three-dimensional environment created by computer. It appeals to the senses of people by reproducing universes close to reality or imaginary. This process is currently the subject of numerous studies in the field of health because it is a non-invasive tool, a non-pharmacological alternative for the management of pain, anxiety and patient satisfaction. People with cancer can have a complex care pathway with psychological, anxiety-provoking and potentially painful repercussions. It is for these reasons that offering VR in the operating room for certain procedures under local anesthesia would improve the experience and comfort of care. BOREV study will assess the interest of VR on pain for procedures under local anesthesia in the operating room in the context of cancer care. The software used, called HypnoVR©, is a medical device, developed specifically for the management of anxiety and pain through hypnosis, sophrology and relaxation techniques. The main objective of this study is to compare the maximum pain felt with and without RV for different oncological surgical procedures performed under local anesthesia including anesthetic procedures and surgical procedures. The secondary objectives that will support this research are: the evaluation of the level of anxiety, the link with the pain component via the Analgesia Nociception Index (ANI), as well as the satisfaction of the patient and the operator. According to the results obtained, the VR device could lead to a change in practice in the management of patients and thus be offered on a larger scale within the framework of the management of pain and anxiety


Description:

Description of the modalities for recruiting : During the preoperative consultation, the surgeon or anesthesiologist presents the study to the patient with a cancer requiring a surgery under local anesthesia. He gives the patient the consent form to participate in the study. Once the consent form has been signed by the patient and the investigator, the investigator prescribes a screening test before surgery. Patients registration and randomization : Any patient who has signed an informed consent form (ICF) must be registered in the eCRF in order to be assigned a patient number. Randomization will be centralized and performed via the eCRF. Patients will be randomly assigned (1:1) at the latest on the day of the surgery. Experimental group : Local anaesthesia + virtual reality versus Control group : Anesthesia only. Surgery period : Regardless of the group, all patients : - Will receive local anaesthesia according to the standard procedure required for the operation - Hemodynamic parameters will be measured - Will be questioned before, immediately after, and at a distance from the surgical procedure on their state of anxiety and immediately after the surgical procedure on the maximum pain felt during the procedure, - Will be questioned on their satisfaction at the end of surgery. ANI will be measured before, during and after the operation in patients included at the Saint Herblain site. A virtual reality headset will be positioned on the patient before the start of the surgical procedure.


Recruitment information / eligibility

Status Recruiting
Enrollment 42
Est. completion date January 2024
Est. primary completion date January 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient aged 18 or more - Patient eligible for surgery under local anaesthesia in the operating room - Written informed consent obtained from the patient - Patient has valid health insurance Exclusion Criteria: - Surgical procedure requiring complementary anaesthetic products such as intravenous sedation, nitrous oxide - Patient requiring an epidural, a paravertebral block - Patient with known allergy(ies) to local anaesthetics - Patient with schizophrenia, seizure disorder - For the investigation site with PhysioDoloris monitor (MDMS): Patient with contraindications to ANI monitoring: Known heart rhythm disorder (complete arrhythmia by atrial fibrillation) Pacemaker Apnea - Administration of a sedative premedication in the 6 hours before the surgery - Visually or hearing impaired patient without a hearing aid - Patient deprived of liberty or under guardianship

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Virtual reality headset
Once the patient is on the operating table, the nurse proposes the different possible VR scenarios and installs the RV headset and an audio headset.

Locations

Country Name City State
France ICO Angers
France ICO Saint-Herblain

Sponsors (1)

Lead Sponsor Collaborator
Institut Cancerologie de l'Ouest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of the maximum subjective pain induced by the surgical procedure Maximum subjective pain is measured by a numerical pain scale of 0 to 10. (0 : no pain ; 10 : maximum pain) Immediately after surgery
Secondary Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of the objective pain induced by the surgical procedure in patients with Analgesia Nociception Index Pain is evaluated in continuous by to the Analgesia Nociception Index (ANI) measured from the PhysioDoloris monitor (MDMS).
It is a unitless index between 0 and 100, which describes:
Pain: 0 = ANI = 40 Discomfort/anxiety: 40 < ANI = 65 Comfort/well-being: 65 < ANI = 100
in preoperative ; during the surgical procedure ; immediate postoperative
Secondary Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of hemodynamic constants Heart rate, blood pressure and respiratory rate measured by a multiparametric monitor type M540 in preoperative ; during the surgical procedure ; immediate postoperative
Secondary Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of anxiety Anxiety is measured by a visual analogue scale of 0 to 10. (0 : no anxiety ; 10 : maximum anxiety) in preoperative ; immediate postoperative ; within 30 minutes after the surgery
Secondary Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of patient satisfaction Satisfaction is evaluated by a Lickert scale (Absolutely satisfied / Somewhat satisfied / Neither satisfied nor dissatisfied / Somewhat dissatisfied / Absolutely dissatisfied) immediate postoperative
Secondary Comparison, between the "local anesthesia + virtual reality" group and the "local anesthesia alone" group, of operator of the surgical procedure Satisfaction is evaluated by a Lickert scale (Absolutely satisfied / Somewhat satisfied / Neither satisfied nor dissatisfied / Somewhat dissatisfied / Absolutely dissatisfied) immediate postoperative
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients